98%
921
2 minutes
20
Titin-based mechanosensing is a key driver of trophic signaling in muscle, yet the downstream pathways linking titin sensing to muscle remodeling remain poorly understood. To investigate these signaling mechanisms, we utilized unilateral diaphragm denervation (UDD), an in vivo model that induces titin-stiffness-dependent hypertrophy via mechanical stretch. Using UDD in rats and mice, we characterized the longitudinal hypertrophic response and distinguished stretch-induced signaling from denervation effects by performing global transcriptomic and proteomic analyses following UDD and bilateral diaphragm denervation (BDD) in rats. Our findings identified upregulation of titin-associated muscle ankyrin repeat proteins (MARPs). Subsequent phosphorylation enrichment mass spectrometry in mouse diaphragm highlighted the involvement of the N2A-element. UDD in MARP knockout (KO) mice resulted in enhanced longitudinal hypertrophy, with Western blot analysis revealing activation of the mTOR pathway. Furthermore, pharmacological inhibition of mTORC1 with rapamycin suppressed longitudinal hypertrophy, demonstrating that mTOR signaling regulates titin-mediated hypertrophic growth in a MARP-dependent manner. These findings establish MARPs as key modulators of titin-based mechanotransduction and highlight mTORC1 as a central regulator of longitudinal muscle hypertrophy.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12262232 | PMC |
http://dx.doi.org/10.1101/2025.06.19.660595 | DOI Listing |
BMC Pregnancy Childbirth
September 2025
Institute of Tropical Medicine of Rio Grande Do Norte, Av. Senador Salgado Filho, 3000, Campus Universitário, Natal, RN, Brazil.
Background: Hypertensive disorders of pregnancy, including preeclampsia, are common in socioeconomic vulnerable populations worldwide. Approximately one third of women who have those disorders will maintain with hypertension, after pregnancy. This work aimed to determine the prevalence of hypertensive disorder of pregnancy in Natal, Brazil, and to use echocardiography to study cardiac function: (1) during pregnancy, and (2) at post partum in those who developed severe preeclampsia.
View Article and Find Full Text PDFPeerJ
September 2025
Changzhou Hospital of Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Nanjing University of Traditional Chinese Medicine, Changzhou, China.
Background: Kidney disease is a major global health issue, causing numerous deaths and a loss of life years. This prompts us to explore potential targets or mechanisms that may increase the likelihood of diagnosing and treating kidney diseases. N6-methyladenosine (mA) modifications dynamically regulate RNA through "writer" enzymes, "eraser" enzymes, and "reader" proteins, influencing its processing, stability, and translation efficiency.
View Article and Find Full Text PDFQuant Imaging Med Surg
September 2025
Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
Background: Although hypertrophy and fibrosis have been identified as contributors to mechanical dysfunction in patients with hypertrophic cardiomyopathy (HCM), their regional distribution and sex differences remain inadequately characterized in those with hypertrophic obstructive cardiomyopathy (HOCM). This study aimed to evaluate the determinants of myocardial strain deterioration across different regions and sexes of patients with HOCM through use of cardiovascular magnetic resonance feature tracking (CMR-FT) techniques.
Methods: This retrospective study included 102 patients with HOCM who underwent 3.
J Am Coll Cardiol
August 2025
Department of Cardiology, University of California-San Francisco, San Francisco, California, USA.
Background: Symptomatic nonobstructive hypertrophic cardiomyopathy (nHCM) lacks approved therapies. The ODYSSEY-HCM trial (A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy; NCT05582395), the largest to date in HCM patients, evaluating the efficacy of mavacamten in symptomatic adults with nHCM, did not demonstrate improvements in its primary endpoints (functional capacity and patient-reported health status).
Objectives: This exploratory analysis of the phase 3, randomized, placebo-controlled trial evaluated echocardiographic changes in nHCM patients from baseline to week 48.
Tissue Barriers
August 2025
Department of Medical and Surgical Sciences, University of Catanzaro "Magna Graecia", Catanzaro, Italy.
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a type 2 inflammatory disease associated with epithelial dysfunction and impaired mucosal barrier integrity. Dupilumab, an IL-4 receptor alpha antagonist, has shown clinical efficacy, but its cellular effects on nasal epithelium remain poorly understood. Advanced in vitro models such as 3D spheroid cultures may provide insight into epithelial organization under treatment.
View Article and Find Full Text PDF